Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12367)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Dec 7, 2014 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Federico A, Zulli C, de Sio I, Del Prete A, Dallio M, Masarone M, Loguercio C. Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver disease. World J Gastroenterol 2014; 20(45): 16841-16857 [PMID: 25492998 DOI: 10.3748/wjg.v20.i45.16841] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i45/16841.htm |
| Number | Citing Articles |
| 1 |
Wenya Meng, Zitong Zhao, Lingli Chen, Suyun Lin, Yang Zhang, Jing He, Kehui Ouyang, Wenjun Wang. Total Flavonoids from Chimonanthus nitens Oliv. Leaves Ameliorate HFD-Induced NAFLD by Regulating the Gut–Liver Axis in Mice. Foods 2022; 11(14): 2169 doi: 10.3390/foods11142169
|
| 2 |
Rebekka Pohl, Lisa Rein-Fischboeck, Elisabeth M. Meier, Kristina Eisinger, Sabrina Krautbauer, Christa Buechler. Resolvin E1 and chemerin C15 peptide do not improve rodent non-alcoholic steatohepatitis. Experimental and Molecular Pathology 2015; 98(2): 295 doi: 10.1016/j.yexmp.2015.02.005
|
| 3 |
Marta Gonzalez Rozas, Lidia Hernanz Roman, Diego Gonzalez Gonzalez, José Luis Pérez-Castrillón. Panhypopituitarism due to Absence of the Pituitary Stalk: A Rare Aetiology of Liver Cirrhosis. Case Reports in Endocrinology 2016; 2016: 1 doi: 10.1155/2016/9071097
|
| 4 |
Tomasz Kostrzewski, Terri Cornforth, Sophie A Snow, Larissa Ouro-Gnao, Cliff Rowe, Emma M Large, David J Hughes. Three-dimensional perfused human <i>in vitro</i> model of non-alcoholic fatty liver disease. World Journal of Gastroenterology 2017; 23(2): 204-215 doi: 10.3748/wjg.v23.i2.204
|
| 5 |
Rohit Anthony Sinha, Paul M. Yen. Thyroid hormone-mediated autophagy and mitochondrial turnover in NAFLD. Cell & Bioscience 2016; 6(1) doi: 10.1186/s13578-016-0113-7
|
| 6 |
Eunsook S. Jin, A. Dean Sherry, Craig R. Malloy. An Oral Load of [13C3]Glycerol and Blood NMR Analysis Detect Fatty Acid Esterification, Pentose Phosphate Pathway, and Glycerol Metabolism through the Tricarboxylic Acid Cycle in Human Liver. Journal of Biological Chemistry 2016; 291(36): 19031 doi: 10.1074/jbc.M116.742262
|
| 7 |
Luigi Marino, Adam Kim, Bin Ni, Francesco S. Celi. Thyroid hormone action and liver disease, a complex interplay. Hepatology 2023; doi: 10.1097/HEP.0000000000000551
|
| 8 |
Weslie Y. Khoo, Benjamin J. Chrisfield, Sudathip Sae-tan, Joshua D. Lambert. Mitigation of nonalcoholic fatty liver disease in high-fat-fed mice by the combination of decaffeinated green tea extract and voluntary exercise. The Journal of Nutritional Biochemistry 2020; 76: 108262 doi: 10.1016/j.jnutbio.2019.108262
|
| 9 |
Jin-ming Zhang, Xing-he Wang, Li-hong Hao, He Wang, Xiu-ying Zhang, Ishfaq Muhammad, Yue Qi, Guang-liang Li, Xiao-qi Sun. Nrf2 is crucial for the down-regulation of Cyp7a1 induced by arachidonic acid in Hepg2 cells. Environmental Toxicology and Pharmacology 2017; 52: 21 doi: 10.1016/j.etap.2017.03.003
|
| 10 |
Tisha R Joy, Charles A McKenzie, Rommel G Tirona, Kelly Summers, Shannon Seney, Subrata Chakrabarti, Neel Malhotra, Melanie D Beaton. Sitagliptin in patients with non-alcoholic steatohepatitis: A randomized, placebo-controlled trial. World Journal of Gastroenterology 2017; 23(1): 141-150 doi: 10.3748/wjg.v23.i1.141
|
| 11 |
Xianghui Huang, Jia Xu, Yingxin Hu, Kunlun Huang, Yunbo Luo, Xiaoyun He. Broccoli ameliorate NAFLD by increasing lipolysis and promoting liver macrophages polarize toward M2-type. Journal of Functional Foods 2022; 89: 104898 doi: 10.1016/j.jff.2021.104898
|
| 12 |
Pegah Golabi, Cameron T Locklear, Patrick Austin, Sophie Afdhal, Melinda Byrns, Lynn Gerber, Zobair M Younossi. Effectiveness of exercise in hepatic fat mobilization in non-alcoholic fatty liver disease: Systematic review. World Journal of Gastroenterology 2016; 22(27): 6318-6327 doi: 10.3748/wjg.v22.i27.6318
|
| 13 |
Lihua Song, Xin Gang Zhao, Peng Ling Ouyang, Qi Guan, Li Yang, Fengju Peng, Huanwang Du, Fei Yin, Wei Yan, Wen Juan Yu, Hongli Yan. Combined effect of n-3 fatty acids and phytosterol esters on alleviating hepatic steatosis in non-alcoholic fatty liver disease subjects: a double-blind placebo-controlled clinical trial. British Journal of Nutrition 2020; 123(10): 1148 doi: 10.1017/S0007114520000495
|
| 14 |
Sha Li, Ning Wang, Yi-Gang Feng, Hong-Yun Li, Yibin Feng. Nutritional Antioxidant Therapies: Treatments and Perspectives. 2017; : 467 doi: 10.1007/978-3-319-67625-8_18
|
| 15 |
Abdelalim A. Gadallah, Abdullah R. Almasari. The effects of a high-fat diet on the liver of pregnant albino rats and their developing offspring. Egyptian Journal of Basic and Applied Sciences 2023; 10(1): 567 doi: 10.1080/2314808X.2023.2245618
|
| 16 |
Mohammed Sharif Swallah, Hongliang Fan, Sainan Wang, Hansong Yu, Chunhong Piao. Prebiotic Impacts of Soybean Residue (Okara) on Eubiosis/Dysbiosis Condition of the Gut and the Possible Effects on Liver and Kidney Functions. Molecules 2021; 26(2): 326 doi: 10.3390/molecules26020326
|
| 17 |
Elizabeth C Verna. Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in patients with HIV. The Lancet Gastroenterology & Hepatology 2017; 2(3): 211 doi: 10.1016/S2468-1253(16)30120-0
|
| 18 |
H. Jin, X. Xu, B. Pang, R. Yang, H. Sun, C. Jiang, D. Shao, J. Shi. Probiotic and prebiotic interventions for non-alcoholic fatty liver disease: a systematic review and network meta-analysis. Beneficial Microbes 2021; 12(6): 517 doi: 10.3920/BM2020.0183
|
| 19 |
Neel Malhotra, Melanie D Beaton. Management of non-alcoholic fatty liver disease in 2015. World Journal of Hepatology 2015; 7(30): 2962-2967 doi: 10.4254/wjh.v7.i30.2962
|
| 20 |
Sebastião Mauro Bezerra DUARTE, José Tadeu STEFANO, Denise Siqueira VANNI, Flair José CARRILHO, Claudia Pinto Marques Souza de OLIVEIRA. IMPACT OF CURRENT DIET AT THE RISK OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD). Arquivos de Gastroenterologia 2019; 56(4): 431 doi: 10.1590/s0004-2803.201900000-67
|
| 21 |
Amrita Kandel, Poonam Pant, Sushila Todi, Sudhamshu KC, Sudip Pandey. Effect of exercise and pharmacotherapy on non-alcoholic fatty liver disease. SAGE Open Medicine 2024; 12 doi: 10.1177/20503121241227090
|
| 22 |
Merilin Al Sharif, Petko Alov, Vessela Vitcheva, Antonia Diukendjieva, Mattia Mori, Bruno Botta, Ivanka Tsakovska, Ilza Pajeva. Natural modulators of nonalcoholic fatty liver disease: Mode of action analysis and in silico ADME-Tox prediction. Toxicology and Applied Pharmacology 2017; 337: 45 doi: 10.1016/j.taap.2017.10.013
|
| 23 |
Jeļizaveta Sokolovska, Sergejs Isajevs, Evita Rostoka, Tatjana Sjakste, Ilva Trapiņa, Kristīne Ošiņa, Natalia Paramonova, Nikolajs Sjakste. Changes in glucose transporter expression and nitric oxide production are associated with liver injury in diabetes. Cell Biochemistry and Function 2015; 33(6): 366 doi: 10.1002/cbf.3123
|
| 24 |
Kandy T Velázquez, Reilly T Enos, Jackie E Bader, Alexander T Sougiannis, Meredith S Carson, Ioulia Chatzistamou, James A Carson, Prakash S Nagarkatti, Mitzi Nagarkatti, E Angela Murphy. Prolonged high-fat-diet feeding promotes non-alcoholic fatty liver disease and alters gut microbiota in mice. World Journal of Hepatology 2019; 11(8): 619-637 doi: 10.4254/wjh.v11.i8.619
|
| 25 |
E. Roeb, A. Canbay. Nichtalkoholische Fettlebererkrankungen. Der Gastroenterologe 2016; 11(3): 205 doi: 10.1007/s11377-016-0063-y
|
| 26 |
Meng‐Meng You, Yi‐Chen Liu, Yi‐Fan Chen, Yong‐Ming Pan, Zhuo‐Ning Miao, Yi‐Zhen Shi, Juan‐Juan Si, Min‐Li Chen, Fu‐Liang Hu. Royal jelly attenuates nonalcoholic fatty liver disease by inhibiting oxidative stress and regulating the expression of circadian genes in ovariectomized rats. Journal of Food Biochemistry 2020; 44(3) doi: 10.1111/jfbc.13138
|
| 27 |
Mohamed Tausif Siddiqui, Hina Amin, Rajat Garg, Pravallika Chadalavada, Wael Al-Yaman, Rocio Lopez, Amandeep Singh. Medications in type-2 diabetics and their association with liver fibrosis. World Journal of Gastroenterology 2020; 26(23): 3249-3259 doi: 10.3748/wjg.v26.i23.3249
|
| 28 |
Yongqing Zhou, Ping Li, Xin Wang, Chuanchen Wu, Nannan Fan, Xiaoning Liu, Lijie Wu, Wei Zhang, Wen Zhang, Zhenzhen Liu, Bo Tang. In situvisualization of peroxisomal viscosity in the liver of mice with non-alcoholic fatty liver disease by near-infrared fluorescence and photoacoustic imaging. Chemical Science 2020; 11(44): 12149 doi: 10.1039/D0SC02922J
|
| 29 |
Hyunjin Park, Yanan Liu, Hyun-Sook Kim, Jung-Hee Shin. Chokeberry attenuates the expression of genes related to de novo lipogenesis in the hepatocytes of mice with nonalcoholic fatty liver disease. Nutrition Research 2016; 36(1): 57 doi: 10.1016/j.nutres.2015.10.010
|
| 30 |
Adriano Lama, Claudio Pirozzi, Maria Pia Mollica, Giovanna Trinchese, Francesca Di Guida, Gina Cavaliere, Antonio Calignano, Giuseppina Mattace Raso, Roberto Berni Canani, Rosaria Meli. Polyphenol‐rich virgin olive oil reduces insulin resistance and liver inflammation and improves mitochondrial dysfunction in high‐fat diet fed rats. Molecular Nutrition & Food Research 2017; 61(3) doi: 10.1002/mnfr.201600418
|
| 31 |
Alessandro Federico, Marcello Dallio, Antonietta Gerarda Gravina, Nadia Diano, Sonia Errico, Mario Masarone, Mario Romeo, Concetta Tuccillo, Paola Stiuso, Filomena Morisco, Marcello Persico, Carmelina Loguercio. The Bisphenol A Induced Oxidative Stress in Non-Alcoholic Fatty Liver Disease Male Patients: A Clinical Strategy to Antagonize the Progression of the Disease. International Journal of Environmental Research and Public Health 2020; 17(10): 3369 doi: 10.3390/ijerph17103369
|
| 32 |
Pratima Dibba, Andrew A. Li, Brandon J. Perumpail, Nimy John, Sandy Sallam, Neha D. Shah, Waiyee Kwong, George Cholankeril, Donghee Kim, Aijaz Ahmed. Emerging Therapeutic Targets and Experimental Drugs for the Treatment of NAFLD. Diseases 2018; 6(3): 83 doi: 10.3390/diseases6030083
|
| 33 |
Bingjian Wen, Chengcheng Zhang, Jingwen Zhou, Zhengyan Zhang, Qishi Che, Hua Cao, Yan Bai, Jiao Guo, Zhengquan Su. Targeted treatment of alcoholic liver disease based on inflammatory signalling pathways. Pharmacology & Therapeutics 2021; 222: 107752 doi: 10.1016/j.pharmthera.2020.107752
|
| 34 |
Wei Jiang, Mei-Hua Guo, Xin Hai. Hepatoprotective and antioxidant effects of lycopene on non-alcoholic fatty liver disease in rat. World Journal of Gastroenterology 2016; 22(46): 10180-10188 doi: 10.3748/wjg.v22.i46.10180
|